|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
173,970,000 |
Market
Cap: |
4.96(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$13.29 - $43.89 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile BridegeBio Pharma identifies and improves medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Co.'s pipeline are: Acoramidis/AG10/BBP-265, a small molecule transthyretin (TTR) stabilizer for the treatment of TTR amyloidosis; Infigratinib/BBP-831, an oral FGFR1-3 selective tyrosine kinase inhibitor for the treatment of achondroplasia; BBP-631, a preclinical adeno-associated virus gene transfer for the treatment of congenital adrenal hyperplasia; and Encaleret, a small molecule antagonist of the calcium sensing receptor for the treatment of Autosomal Dominant Hypocalcemia Type 1.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
5,415 |
192,897 |
1,845,608 |
2,886,602 |
Total Sell Value |
$195,041 |
$7,018,061 |
$62,779,686 |
$73,415,196 |
Total People Sold |
2 |
5 |
6 |
6 |
Total Sell Transactions |
2 |
10 |
16 |
29 |
End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Kumar Neil |
CEO and President |
|
2021-02-17 |
4 |
A |
$62.50 |
$1,000,000 |
D/D |
16,000 |
4,711,425 |
|
- |
|
Scott Randal W |
Director |
|
2021-02-17 |
4 |
B |
$62.50 |
$1,000,000 |
D/D |
16,000 |
21,000 |
2.39 |
-8% |
|
Stephenson Brian C |
See Remarks |
|
2021-02-17 |
4 |
B |
$62.50 |
$500,000 |
D/D |
8,000 |
300,043 |
2.74 |
-8% |
|
Roberts George R |
|
|
2021-02-17 |
4 |
S |
$60.47 |
$208,617,360 |
I/I |
(3,450,000) |
31,060,971 |
|
8% |
|
Kumar Neil |
CEO and President |
|
2021-02-16 |
4 |
D |
$64.98 |
$138,992 |
D/D |
(2,139) |
4,695,425 |
|
- |
|
Kumar Neil |
CEO and President |
|
2021-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,129 |
4,697,564 |
|
- |
|
Stephenson Brian C |
See Remarks |
|
2021-02-16 |
4 |
D |
$64.98 |
$38,468 |
D/D |
(592) |
292,043 |
|
- |
|
Stephenson Brian C |
See Remarks |
|
2021-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,710 |
292,635 |
|
- |
|
Turtle Cameron |
See Remarks |
|
2020-12-28 |
4 |
AS |
$69.34 |
$1,357,184 |
D/D |
(19,500) |
12,568 |
|
-31% |
|
Turtle Cameron |
See Remarks |
|
2020-12-28 |
4 |
OE |
$0.16 |
$130,500 |
D/D |
19,500 |
32,068 |
|
- |
|
Scheller Richard H |
See Remarks |
|
2020-12-21 |
4 |
S |
$64.81 |
$3,945,137 |
D/D |
(60,401) |
45,860 |
|
16% |
|
Scheller Richard H |
See Remarks |
|
2020-12-18 |
4 |
S |
$64.99 |
$1,952,021 |
D/D |
(30,000) |
106,261 |
|
14% |
|
Scheller Richard H |
See Remarks |
|
2020-12-15 |
4 |
S |
$59.81 |
$1,898,417 |
D/D |
(31,443) |
136,261 |
|
9% |
|
Scheller Richard H |
See Remarks |
|
2020-12-15 |
4 |
OE |
$17.00 |
$497,709 |
D/D |
29,277 |
167,704 |
|
- |
|
Henderson Michael Thomas |
Chief Business Officer |
|
2020-12-01 |
4 |
AS |
$51.12 |
$515,204 |
D/D |
(10,000) |
274,211 |
|
7% |
|
Henderson Michael Thomas |
Chief Business Officer |
|
2020-12-01 |
4 |
OE |
$1.05 |
$10,500 |
D/D |
10,000 |
284,211 |
|
- |
|
Turtle Cameron |
See Remarks |
|
2020-11-25 |
4 |
AS |
$47.23 |
$35,044 |
D/D |
(742) |
12,568 |
|
20% |
|
Turtle Cameron |
See Remarks |
|
2020-11-25 |
4 |
OE |
$17.00 |
$12,614 |
D/D |
742 |
13,310 |
|
- |
|
Turtle Cameron |
See Remarks |
|
2020-11-24 |
4 |
AS |
$47.00 |
$200,137 |
D/D |
(4,258) |
12,568 |
|
19% |
|
Turtle Cameron |
See Remarks |
|
2020-11-24 |
4 |
OE |
$17.00 |
$72,386 |
D/D |
4,258 |
16,826 |
|
- |
|
Yau Yi Ching |
Chief Accounting Officer |
|
2020-11-16 |
4 |
D |
$44.33 |
$84,227 |
D/D |
(1,900) |
4,586 |
|
- |
|
Yau Yi Ching |
Chief Accounting Officer |
|
2020-11-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,493 |
6,486 |
|
- |
|
Stephenson Brian C |
See Remarks |
|
2020-11-16 |
4 |
D |
$44.33 |
$26,243 |
D/D |
(592) |
290,085 |
|
- |
|
Stephenson Brian C |
See Remarks |
|
2020-11-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,710 |
290,677 |
|
- |
|
Kumar Neil |
CEO and President |
|
2020-11-16 |
4 |
D |
$44.33 |
$78,641 |
D/D |
(1,774) |
4,692,435 |
|
- |
|
288 Records found
|
|
Page 6 of 12 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|